Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$3.0 million upfront with up to approximately $6.0 million of potential additional…
TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan
July 07, 2026 19:00 ET | Source: TaiMed Biologics TAIPEI, July 07,…
Resmed Announces Agreement to Sell MatrixCare Business
SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX:…
As AI Moves Into the Physical World, Humanity & AGI Summit 2026 Brings Global Leaders to Stanford
STANFORD, CA, July 07, 2026 (GLOBE NEWSWIRE) -- The AI Robotics Alliance…
Eavor Advances Next-Generation Geothermal Technology with Support from the Government of Alberta
CALGARY, Alberta, July 07, 2026 (GLOBE NEWSWIRE) -- Eavor Technologies Inc. (Eavor),…
EPA Administrator Lee Zeldin Tours Revive Environmentals Columbus Headquarters, the Nations First Commercial PFAS Destruction Facility
COLUMBUS, Ohio, July 07, 2026 (GLOBE NEWSWIRE) -- U.S. Environmental Protection Agency…
Presentation of New Clinical Data on Givinostat in Duchenne Muscular Dystrophy at ICNMD 2026
Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle…
ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs
Investigational n.c.a. 177Lu-edotreotide (ITM-11) demonstrated a significantly higher progression-free survival and objective…
Levicept Appoints Darlene Deptula-Hicks as CFO
Highly Experienced US-Based Public Markets Leader Strengthens Team as Company Drives Late…
SalesCloser Technologies to Commence Trading on the OTCQB Venture Market
Vancouver, BC, July 06, 2026 (GLOBE NEWSWIRE) -- SalesCloser Technologies Ltd. (“SalesCloser”…
